[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Is global vaccination still required?", "description": "Probably not\n\nDirect link to featured report and channel, https://www.youtube.com/watch?v=o9YfCjRyKnY\n\nhttps://www.youtube.com/c/WefwafwaAndrew\n\nhttps://www.nytimes.com/2022/04/23/health/covid-vaccines-world-africa.html\n\nWHO, fully vaccinate 70% in every country by June 2022\n\nAfrican Union also wants 70%\n\nAt 70%\n\nBangladesh, Bhutan, Cambodia Nepal\n\nMost others under 20%\n\nDr. Seth Berkley, chief executive Gavi, Covax\n\nThis pandemic is not over yet \u2014 far from it \u2014 and it\u2019s imperative that countries use the doses available to them to protect as much of their population as possible\n\nGavi, secured $4.8 billion\n\nAfrica\u2019s vaccination rate\n\nFewer than 17% have received a primary immunization\n\nLast month, vaccinations down 35% in Arica\n\nDr. Isaac Adewole, Nigeria, Africa Centers for Disease Control and Prevention.\n\nWould like 70%\n\nThere was a time people were very desperate to get vaccinated, but the vaccines were not there. And then they realized that without the vaccination, they didn\u2019t die\n\nWhite House, global covid summit in May, hopes for renewed funding\n\nDemocratic Republic of Congo\n\nCovid death rate very low\n\nSurge in measles threatening 20 million children\n\nChristopher Mambula, Doctors Without Border, East Africa\n\nDRC government cannot spare resources for supplementary measles vaccinations\n\nSerum Institute of India\n\nStopped producing covid vaccines last December\n\nBefore omicron\n\nAt least 66% of Africans already infected\n\n\nShabir Madhi, professor, University of the Witwatersrand\n\nThere\u2019s very little value to it. In fact, we will gain much more by getting to more than 90% above the age of 50", "link": "https://www.youtube.com/watch?v=CxubdPKLoxc", "date_published": "2022-04-27 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "No BA.2 US bounce", "description": "Or at least very small one, this is good news. I had anticipated an increase as BA.2 and its sub-variants spread throughout the United States. However, it seems that the BA.1 wave generated more natural  immunity than it did in the UK. Also the infections in the States are mostly mild or asymptomatic.", "link": "https://www.youtube.com/watch?v=42zrjcFjYIU", "date_published": "2022-04-27 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Waning vaccine efficacy in the UK", "description": "Beijing, 70 cases since Friday\n\nThree P.C.R. tests over five days\n\nzero Covid strategy\n\nhttps://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1070356/Vaccine-surveillance-report-week-16.pdf\n\nEffectiveness against symptomatic disease \n\nAfter 2 doses of the AstraZeneca\n\nAgainst the Omicron variant\n\nStarts at 45 to 50%\n\nDrops to almost no effect, 25 weeks after the second dose\n\nWith 2 doses of Pfizer or Moderna\n\nEffectiveness dropped from around 65 to 70%\n\nDown to around 15% by 25 weeks after the second dose\n\nTwo to 4 weeks after a booster dose\n\nEffectiveness ranges from around 60 to 75%\n\nDropping to almost no effect from 20+ weeks after the booster\n\n Effectiveness against hospitalisation \n\nAlpha and Delta variants\n\nHigher levels of protection against hospitalisation with all vaccines\n\nOmicron\n\n18 to 64 year olds\n\nAll COVID-19 cases admitted via emergency care\n\nVE after a booster peaked at 82.4%\n\nDropped to 53.6% by 15+ weeks after the booster\n\nNeeded oxygen/ventilated\n\nVE 97.1% down to 75.9%\n\nAlso\n\nOmicron generally causes milder disease,\nin particular among younger individuals\n\nAll individuals who are hospitalised are tested for COVID-19\nAn increasing proportion of individuals hospitalised with a positive COVID- 19 test are likely to have COVID-19 as an incidental finding rather than the primary reason for admission. \n\nAll 3 vaccines give similar protection against hospitalisation\n\nEffectiveness against mortality \n\nAlpha and Delta\n\nOver 90% protection against mortality with all 3 vaccines\n\nVaccine effectiveness against mortality with Omicron\n\nAt 25-plus weeks following the second dose, \nvaccine effectiveness was around 60%", "link": "https://www.youtube.com/watch?v=01qdCw2cMzg", "date_published": "2022-04-26 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]